Dr. Neva Lazarova is a distinguished expert at the Risk Analytics
Institute with extensive experience in research, strategic leadership, and project management.
Her diverse background spanning academic, government, and industrial organizations has
positioned her as a leading authority in chemistry, innovation, and business development. Dr.
Lazarova's expertise in radiochemistry and her current focus on ESG research contribute
significantly to the institute's multidisciplinary approach to risk analytics and management.
Her educational background includes:
A Ph.D. in Chemistry from Syracuse University.
An MBA in Management of Technology and Innovation from Ryerson University.
A B.Sc. in Chemistry from Baylor University.
Dr. Lazarova is currently preparing a number of course modules that will contribute to the course
materials at the Risk Analytics Institute, with a focus on ESG topics.
In terms of her work background, Dr. Lazarova has:
Over 10 years of experience at IBA, currently serving as Collaborations and Innovation
Director in chemistry.
Expertise in developing new products and services, analyzing market trends, and defining R&D roadmaps.
Experience in managing R&D projects and leading cross-functional teams.
A background in business development and commercialization of scientific and technological
products.
Significant experience in regulatory affairs and compliance in the pharmaceutical industry.
A track record of initiating and completing projects from early drug discovery to
commercialization.
Dr. Lazarova's areas of interest and expertise include:
ESG research and its applications in risk management.
Innovation management and strategic leadership in scientific fields.
Radiochemistry and molecular imaging for early disease detection.
Regulatory compliance in pharmaceutical R&D and drug approvals.
